Physician profile
Sergey Terushkin
NPI 1245424506
$12,545.71
in general payments reported to CMS, 2019-2025
27 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $17.65 · 2021: $95.62 · 2022: $1,326 · 2023: $3,357 · 2024: $5,282 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $2,367 · Travel and Lodging: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $2,366.51 |
| Travel and Lodging | $708.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,023.58 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $395.84 | 2023-2025 | Floseal, Perclot, Tisseel |
| Novo Nordisk INC | $318.93 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Standard Bariatrics, INC. | $250.00 | 2019 | |
| Medtronic, INC. | $192.80 | 2024 | Signia |
| Ethicon US, LLC | $185.94 | 2021-2024 | Echelon Flex, Linx Reflux Management System |
| Tela Bio, INC. | $155.04 | 2024 | Ovitex 2s |
| Intra-Sana Laboratories | $149.30 | 2021-2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Allergan, INC. | $132.84 | 2019 | |
| Cook Medical LLC | $130.44 | 2019 | |
| Teleflex LLC | $68.81 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Polynovo North America LLC | $67.21 | 2024 | Novosorb Btm |
| Kerecis Limited | $65.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $60.90 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Arcutis Biotherapeutics, INC. | $57.95 | 2024-2025 | Zoryve |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $49.62 | 2024-2025 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $32.01 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.82 | 2023 | Gattex |
| Mimedx Group, INC. | $26.02 | 2025 | |
| Heron Therapeutics, INC. | $25.00 | 2023 | Zynrelef |
| Depuy Synthes Sales INC. | $23.55 | 2022 | |
| Mesh Suture INC | $19.49 | 2025 | |
| Solventum Corporation | $19.02 | 2024 | V.A.C.Instill, Prevena, Bair Hugger |
| Covidien LP | $17.65 | 2020 | |
| Lilly USA, LLC | $17.53 | 2025 | Zepbound |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2025 | Exparel |
| Kci USA, INC. | $14.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Terushkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.